American Society for Clinical Investigation, Inc., The – Trademark Portfolio
Entity Type: 03
American Society for Clinical Investigation, Inc., The holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 16 (Paper Goods) — 4 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include JCI and THE JOURNAL OF CLINICAL INVESTIGATION. The owner is based in Potomac, MD.
10706 Great Arbor Dr.
Potomac, MD 20854
Showing of trademarks Trademarks
Trademark Classifications
American Society for Clinical Investigation, Inc., The's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does American Society for Clinical Investigation, Inc., The have?
American Society for Clinical Investigation, Inc., The has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.
What trademark classes does American Society for Clinical Investigation, Inc., The file in?
American Society for Clinical Investigation, Inc., The files trademarks across 1 Nice Classification class. The most active classes are Class 16 (Paper Goods). Class 16 covers paper and cardboard; printed matter; bookbinding material; photographs; stationery.
What are American Society for Clinical Investigation, Inc., The's most well-known trademarks?
American Society for Clinical Investigation, Inc., The's registered trademark portfolio includes well-known marks such as JCI and THE JOURNAL OF CLINICAL INVESTIGATION. These are among 2 currently registered trademarks in the portfolio.
What is American Society for Clinical Investigation, Inc., The's trademark registration success rate?
American Society for Clinical Investigation, Inc., The has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.